Clinical trial
Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
NCT00408525 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00408525 |
|---|---|
| Title | Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease |
| Official title | Efficacy of Donepezil in Normalizing Brain Activation Patterns in People Genetically at Risk for Alzheimer's Disease |
| Lead sponsor | Vanderbilt University, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | donepezil |
| Enrollment | 41 |
| Start date | Dec 1, 2006 |
| Primary completion | Aug 24, 2012 |
| Completion | Aug 24, 2012 |
| First posted | Dec 7, 2006 |
| Last update posted | Feb 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: